On September 4, 2024 Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, reported that Company management will present at the following conferences in September 2024 (Press release, Sensei Biotherapeutics, SEP 4, 2024, View Source [SID1234646347]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 26th Annual Global Investment Conference
Corporate Presentation
Monday, September 9, 2024, at 7:00 a.m. ET.
Virtual and New York, NY

2024 Cantor Fitzgerald Global Healthcare Conference
Fireside Chat
Wednesday, September 18, 2024, at 2:30 p.m. ET.
New York, NY

Webcasts of both presentations will be available on the Investors section of the Sensei website. Replays will be on the website for approximately 90 days following the events.